Johnson & Johnson (JNJ) fundamentals from SEC filings — revenue $94.2B, net margin 28.5%, diluted EPS $11.03 in FY2025. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $82.6B | $78.7B | $85.2B | $88.8B | $94.2B |
| Net income | $14.7B | $20.9B | $35.2B | $14.1B | $26.8B |
| Net margin | 17.8% | 26.5% | 41.3% | 15.8% | 28.5% |
| Diluted EPS | $5.51 | $7.81 | $13.72 | $5.79 | $11.03 |
| Free cash flow | $20.2B | $19.8B | $18.2B | $19.8B | $19.7B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home